Spine tech startup Benvenue Medical has secured a $40 million Series E, plus $24 million in debt financing, to further commercialization efforts in the States, upscale manufacturing and support growth. The Santa Clara, California-based company launched its Kiva VCF in March. Back then, CEO Robert Weigle said the company was “blessed to be fully funded […]
Integrated Diagnostics has an interesting proposal for a blood test. Instead of telling doctors that lung cancer is present in a patient with lung nodules, it’s aiming to tell them when it’s not present. The Seattle-based company has just pulled in a $30 million Series B led by Baird Capital and joined by InterWest Partners […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
St. Jude Medical (STJ) announced it has acquired Nanostim, Inc., a California-based early-stage medical device company focused on leadless pacemaker technology, for $123.5 million. The startup could stand to gain up to an additional $65 million if it meets certain milestones. This deal culminates a partnership that began on May 3, 2011, when STJ decided […]
Earlier this summer, we saw the first “smart pill” from Proteus Digital Health receive U.S. Food and Drug Administration clearance, a huge step in connecting drug delivery with mobile technologies. So what comes next? It would be years before we see it on the market, but the next generation of smart medicine just may lie […]
On the heels of FDA approval of its new anti-spasticity drug Gablofen, CNS Therapeutics has raised $3 million in equity, according to documents filed with the Securities and Exchange Commission.
Drug companies are rare in medical-device crazed Minnesota. Even more rare is a startup that can win approval from the Food and Drug Administration, given the cost and regulatory hurdles of pushing drugs to market, these days. So it’s heartening to see the FDA approval of Gablofen (who thinks of these names anyway?), a movement […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
CVRx Inc. in Plymouth, Minn. said Monday that hypertension patients using its Rheos stimulation device reported a sharp drop in blood pressure after four years. In a study presented to the European Society of Hypertension meeting, the company said patients’ average systolic blood pressure dropped 27 percent to 140 mmHg (millimeters of mercury) from 193 […]
Previous investors InterWest Partners and Thomas McNerney Partners led the round. The company raised $6 million last year, according to filing with the Securities and Exchange Commission.
Autonomic is creating a small, implantable medical device to treat severe headaches, according to a news release from InterWest. It was created in 2007 through research by Clinic neurologist Dr. Ali Rezai, who remains on the company's board.
The autoimmune drug-maker Lycera will fund testing on two of its drugs. One drug will go through Phase II proof-of-concept studies while another will move into Phase I clinical trials, according to the release.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.